001     258692
005     20240808173021.0
024 7 _ |a pmc:PMC11102398
|2 pmc
024 7 _ |a 10.1007/s12311-023-01547-z
|2 doi
024 7 _ |a pmid:37020147
|2 pmid
024 7 _ |a 1473-4222
|2 ISSN
024 7 _ |a 1473-4230
|2 ISSN
024 7 _ |a altmetric:146062318
|2 altmetric
037 _ _ |a DZNE-2023-00665
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Klockgether, Thomas
|0 P:(DE-2719)2810314
|b 0
|e First author
245 _ _ |a Consensus Recommendations for Clinical Outcome Assessments and Registry Development in Ataxias: Ataxia Global Initiative (AGI) Working Group Expert Guidance.
260 _ _ |a London
|c 2024
|b Dunitz
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1716276944_21512
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To accelerate and facilitate clinical trials, the Ataxia Global Initiative (AGI) was established as a worldwide research platform for trial readiness in ataxias. One of AGI's major goals is the harmonization and standardization of outcome assessments. Clinical outcome assessments (COAs) that describe or reflect how a patient feels or functions are indispensable for clinical trials, but similarly important for observational studies and in routine patient care. The AGI working group on COAs has defined a set of data including a graded catalog of COAs that are recommended as a standard for future assessment and sharing of clinical data and joint clinical studies. Two datasets were defined: a mandatory dataset (minimal dataset) that can ideally be obtained during a routine clinical consultation and a more demanding extended dataset that is useful for research purposes. In the future, the currently most widely used clinician-reported outcome measure (ClinRO) in ataxia, the scale for the assessment and rating of ataxia (SARA), should be developed into a generally accepted instrument that can be used in upcoming clinical trials. Furthermore, there is an urgent need (i) to obtain more data on ataxia-specific, patient-reported outcome measures (PROs), (ii) to demonstrate and optimize sensitivity to change of many COAs, and (iii) to establish methods and evidence of anchoring change in COAs in patient meaningfulness, e.g., by determining patient-derived minimally meaningful thresholds of change.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Activities of daily living (ADL)
|2 Other
650 _ 7 |a Ataxia
|2 Other
650 _ 7 |a Clinical outcome assessment (COA)
|2 Other
650 _ 7 |a Scale for the assessment and rating of ataxia (SARA)
|2 Other
650 _ 7 |a Standardization
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Ataxia: therapy
|2 MeSH
650 _ 2 |a Ataxia: diagnosis
|2 MeSH
650 _ 2 |a Outcome Assessment, Health Care: standards
|2 MeSH
650 _ 2 |a Outcome Assessment, Health Care: methods
|2 MeSH
650 _ 2 |a Registries: standards
|2 MeSH
650 _ 2 |a Consensus
|2 MeSH
650 _ 2 |a Clinical Trials as Topic: standards
|2 MeSH
650 _ 2 |a Clinical Trials as Topic: methods
|2 MeSH
700 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 1
|e Last author
700 1 _ |a COAs, AGI working group on
|b 2
700 1 _ |a Registries
|b 3
|e Collaboration Author
700 1 _ |a Alhusaini, Saud
|b 4
|e Contributor
700 1 _ |a Anheim, Mathieu
|b 5
|e Contributor
700 1 _ |a Antonijevic, Irina
|b 6
|e Contributor
700 1 _ |a Ashizawa, Tee
|b 7
|e Contributor
700 1 _ |a Bataller, Luis
|b 8
|e Contributor
700 1 _ |a Berard, Mélanie
|b 9
|e Contributor
700 1 _ |a Bertini, Enrico
|b 10
|e Contributor
700 1 _ |a Boesch, Sylvia
|b 11
|e Contributor
700 1 _ |a Braga-Neto, Pedro
|b 12
|e Contributor
700 1 _ |a Cassou, Emanuel
|b 13
|e Contributor
700 1 _ |a Chan, Edwin
|b 14
|e Contributor
700 1 _ |a Chuang, Rosalind
|b 15
|e Contributor
700 1 _ |a Collins, Abbie
|b 16
|e Contributor
700 1 _ |a Damásio, Joana
|b 17
|e Contributor
700 1 _ |a Donis, Karina
|b 18
|e Contributor
700 1 _ |a Duquette, Antoine
|b 19
|e Contributor
700 1 _ |a Durães, João
|b 20
|e Contributor
700 1 _ |a Durr, Alexandra
|0 P:(DE-HGF)0
|b 21
|e Contributor
700 1 _ |a Evans, Rebecca
|b 22
|e Contributor
700 1 _ |a Faber, Jennifer
|0 P:(DE-2719)2811327
|b 23
|e Contributor
|u dzne
700 1 _ |a Farmer, Jennifer
|b 24
|e Contributor
700 1 _ |a Gennarino, Vincenzo
|b 25
|e Contributor
700 1 _ |a Graessner, Holm
|b 26
|e Contributor
700 1 _ |a Grobe-Einsler, Marcus
|0 P:(DE-2719)9001510
|b 27
|e Contributor
|u dzne
700 1 _ |a Hanagasie, Hasmet
|b 28
|e Contributor
700 1 _ |a Heidari, Morteza
|b 29
|e Contributor
700 1 _ |a Houlden, Henry
|b 30
|e Contributor
700 1 _ |a Indelicato, Elisabetta
|b 31
|e Contributor
700 1 _ |a Ishikawa, Kinya
|b 32
|e Contributor
700 1 _ |a Jacobi, Heike
|0 P:(DE-HGF)0
|b 33
|e Contributor
700 1 _ |a Jardim, Laura
|b 34
|e Contributor
700 1 _ |a Kisanuki, Yaz
|b 35
|e Contributor
700 1 _ |a Kopishinskaia, Svetlana
|b 36
|e Contributor
700 1 _ |a L Italien, Gilbert
|b 37
|e Contributor
700 1 _ |a Maas, Roderick
|b 38
|e Contributor
700 1 _ |a Mancuso, Michelangelo
|b 39
|e Contributor
700 1 _ |a Mariotti, Caterina
|b 40
|e Contributor
700 1 _ |a Ibrahim, Norlinah Mohamed
|b 41
|e Contributor
700 1 _ |a Nachbauer, Wolfgang
|b 42
|e Contributor
700 1 _ |a Nemeth, Andrea
|b 43
|e Contributor
700 1 _ |a Ng, Yi Shiau
|b 44
|e Contributor
700 1 _ |a Obieglo, Katja
|b 45
|e Contributor
700 1 _ |a Onodera, Osamu
|b 46
|e Contributor
700 1 _ |a Opal, Puneet
|b 47
|e Contributor
700 1 _ |a de Almeida, Luis Pereira
|b 48
|e Contributor
700 1 _ |a Perlman, Susan
|b 49
|e Contributor
700 1 _ |a Primiano, Guido
|b 50
|e Contributor
700 1 _ |a Renaud, Mathilde
|b 51
|e Contributor
700 1 _ |a Rosenthal, Liana
|b 52
|e Contributor
700 1 _ |a Saccà, Francesco
|b 53
|e Contributor
700 1 _ |a Sattar, Zahid
|b 54
|e Contributor
700 1 _ |a Schmitz-Hübsch, Tanja
|0 P:(DE-HGF)0
|b 55
|e Contributor
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 56
|e Contributor
|u dzne
700 1 _ |a Schüle-Freyer, Rebecca
|0 P:(DE-2719)2812018
|b 57
|e Contributor
|u dzne
700 1 _ |a Seeberger, Lauren
|b 58
|e Contributor
700 1 _ |a Silvestri, Gabriella
|b 59
|e Contributor
700 1 _ |a Sobanska, Anna
|b 60
|e Contributor
700 1 _ |a Soong, Bin-Weng
|b 61
|e Contributor
700 1 _ |a Srivastava, Achal Kumar
|b 62
|e Contributor
700 1 _ |a Stoyas, Colleen
|b 63
|e Contributor
700 1 _ |a du Montcel, Sophie Tezenas
|b 64
|e Contributor
700 1 _ |a Thieme, Andreas
|b 65
|e Contributor
700 1 _ |a Timmann, Dagmar
|b 66
|e Contributor
700 1 _ |a Tocoian, Adina
|b 67
|e Contributor
700 1 _ |a Traschuetz, Andreas
|0 P:(DE-2719)9000792
|b 68
|e Contributor
|u dzne
700 1 _ |a van de Warrenburg, Bart
|b 69
|e Contributor
700 1 _ |a Ziegler, Wolfram
|b 70
|e Contributor
773 _ _ |a 10.1007/s12311-023-01547-z
|0 PERI:(DE-600)2071266-2
|n 3
|p 924 - 930
|t The Cerebellum
|v 23
|y 2024
|x 1473-4222
856 4 _ |u https://link.springer.com/article/10.1007/s12311-023-01547-z
856 4 _ |u https://pub.dzne.de/record/258692/files/DZNE-2023-00665.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/258692/files/DZNE-2023-00665.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:258692
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810314
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811275
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 23
|6 P:(DE-2719)2811327
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 27
|6 P:(DE-2719)9001510
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 56
|6 P:(DE-2719)2810795
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 57
|6 P:(DE-2719)2812018
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 68
|6 P:(DE-2719)9000792
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-17
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-17
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2022-11-17
|w ger
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CEREBELLUM : 2022
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-24
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-24
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
920 1 _ |0 I:(DE-2719)1011001
|k AG Klockgether
|l Patient Studies
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)1011001
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21